• market

  PRIVATE

• industry

  Biotechnology

• website

  www.catalym.com

Catalym is a healthcare company focused on developing immunotherapy for solid tumors. They have identified GDF-15 as a key cancer therapy resistance mechanism and are developing a safe and efficacious immune therapy for solid tumors.